Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2023 · 10-Q
Revenue$289.27M$289.27M+4.7% vs Q2 2022 Net Income$51.02M$51.02M+12.6% vs Q2 2022 EPS Diluted$1.02$1.02+14.6% vs Q2 2022 Gross Profit$161,009,000+2.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,540,000−6.0% Free Cash Flowderived$55,164,000−5.6% Margins · derivedGross margin55.7%−1.4 pt vs Q2 2022
Operating margin29.2%+0.7 pt vs Q2 2022
Net margin17.6%+1.2 pt vs Q2 2022
ended Sep 30, 2022 · filed Nov 3, 2022 · 34 d after period end